Motiva USA update: >1,000 surgeons, Q2 sales guide $9.5-10M, reconstruction filing Q4 2025

ESTABLISHMENT LABS HOLDINGS INC.

Over 1,000 surgeons now offer Motiva implants in the United States.
Q2 2025 Motiva US sales expected $9.5M–$10M (partial quarter).
Company to seek US FDA approval for Motiva reconstruction use in Q4 2025.
Preservé US launch anticipated in first half of 2026.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.